|
 |
Message from CEO |
 |
 Thank you for visiting the Investor Relations section of our website. Our business philosophy clearly states that the raison d'être of Astellas is to contribute to the health of people around the world through the provision of innovative and reliable pharmaceuticals, and our mission is to enhance its enterprise value in a sustainable manner. We are currently working to achieve the targets contained in our Vision 2015, which shows the roadmap and direction to realize our business philosophy. Specifically, we aim to achieve sustainable growth and to maximize the Company's enterprise value by developing a business model called "Global Category Leader," which provides high value-added products on a global scale in several categories where a high degree of expertise is required. We will continue improving the contents in this IR section of our website, and the timely disclosure of accurate information for a better understanding of Astellas among our stakeholders. I look forward to receiving your continued support and encouragement. April 2008 |
Disclaimer for Share Price Feed
The past performance of the price of securities must not be relied on as a guide to their future performance. Astellas pharma inc. has not reviewed, is not responsible for, and accepts no liability in respect of, any information or opinion contained on any other website.
For more detail information, please refer to Cautionary Statement.
- IR TOP
- Top Message
- Message from CEO
- Business Philosophy / Business Plan
- VISION2015
- Medium-Term Plan
- CSR-Based Management
- Corporate Governance
/ Internal Control - Financial Information
- Stock & Bond Information
- IR Calendar
- IR Library
 |
 |
 |
 |
 |
 |
 |